Pharmacology Chapter 12

  1. The general indication for clinical use of nonsteroidal antiasthma agents is:



    C. prophylactic management of mild persisten asthma
  2. Nonsteroidal antiasthma drugs are:



    A. controllers
  3. The brand name for cromolyn sodium is:



    C. Intal
  4. Cromolyn sodium is available in all of the following forms except:



    D. tablet
  5. Which of the following are antileukotrienes?
    I. Zafirlukast
    II. Zileuton
    III. Cromolyn Sodium
    IV. Montelukast
    V. Nedocromil Sodium



    C. I, II, and IV only
  6. Cromolyn sodium is effective in preventing bronchospasm by:



    A. inhibiting mast cell degranulation
  7. The most commonly reported side effect of cromolyn sodium is:



    B. nasal congestion
  8. The usual dose of nebulized cromolyn sodium is:



    C. 20 mb 4xday
  9. Nedocromil Sodium is administered by:



    B. MDI
  10. Tilade is effective as an intiinflammatory by inhibiting activation and activity of which of the following?
    I. sensory neurons
    II. mast cells
    III. airway epithelial cells
    IV. eosinophils



    A. I, II, III, and IV
  11. It has been suggested that intal and tilade are effective as antiinflammatory agents by blocking transport of what ion into inflammatory celss?



    C. chloride
  12. Leukotrienes exhibit which of the following effects?
    I. incr mucus secretion
    II. inhibition of normal ciliary action
    III. incr airway edem
    IV. bronchoconstriction
    V. recruitment of other inflammatory cells into airways



    C. I, II, III, IV, and V
  13. Zileuton interacts with which of the following respiratory care drugs?
    I. theophylline
    II. albuterol
    III. warfarin
    IV. ipratropium bromide
    V. beclamethasone



    D. I and III only
  14. Zafirlukast is a :



    C. leukotriene receptor antagonist
  15. The only antileukotriene agent currently approved for use in ped patients:



    A. singulair
  16. What is clinical indication for use of leukotriene modifiers, such as montelukast, in asthma?



    C. alternative to or in combo with inhaled steroids
  17. After a patient begins cromolyn sodium, how long may it take to show improvement in symptoms?



    D. 2-4 weeks
  18. Which of the following is considered a mast cell stabilizer?



    A. cromolyn sodium
  19. Which of the following nonsteroidal antiasthma agents is formulated as an MDI?



    C. nedocromil
  20. Which of the following is a monocolonal antibody used to reat asthma?



    C. omalizumab
  21. Advantages to the use of antileukotrienes include all of the following except:



    C. effective in more than 90% of patients
  22. Which drug is a lipid-soluble, intracellular receptor agonist that prevents inflammatory response?



    C. flovent
Author
tswhite
ID
84103
Card Set
Pharmacology Chapter 12
Description
Pharmacology Study Guide Chapter 12
Updated